1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Italy >
  5. Opocrin Acquires LDO

M&A Deal Summary

Opocrin Acquires LDO

On April 29, 2020, Opocrin acquired life science company LDO from Cerus Advisors DMCC

Acquisition Highlights
  • This is Opocrin’s 1st transaction in the Life Science sector.
  • This is Opocrin’s 1st transaction in Italy.

M&A Deal Summary
Date 2020-04-29
Target LDO
Sector Life Science
Buyer(s) Opocrin
Sellers(s) Cerus Advisors DMCC
Deal Type Add-on Acquisition

Target

LDO

Trino, Italy
LDO S.p.A. (Laboratori Derivati Organici) has focussed its manufacturing activities on the extraction of active pharmaceutical ingredients from animal organs, specializing in the manufacture of heparin and its derivatives. Its expertise in the extraction and purification of APIs, accrued over decades of manufacture and research, has made LDO a leading manufacturer of Glycosaminoglycans, and it now exports its products to customers worldwide, from multinational corporations to small local businesses in the pharmaceutical, cosmetics and nutrition sectors. LDO was formed in 1960 and is based in Trino, Italy.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Opocrin

Modena, Italy
Category Company
Sector Life Science
DESCRIPTION

Opocrin S.p.A. is a global manufacturer of Active Pharmaceutical Ingredients ("API"). The company is a main producer of heparin and its derivatives worldwide, with an expected 2020 turnover higher than €170 million.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Italy M&A 1 of 1
Year: 2020 M&A 1 of 1

Seller(S) 1

SELLER

Cerus Advisors DMCC

Category Merchant Bank
Size Small
Type Sector Focused
DESCRIPTION

Cerus Advisors DMCC is a boutique private equity and real estate investment firm partnering with entrepreneurs and companies across North America and the Middle East. The Firm’s capabilities include growth capital, venture investments, and strategic financing tailored to life sciences, healthcare technologies, and commercial real estate. Cerus Advisors DMCC was founded in 2012 and is headquartered in Dubai.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Italy M&A 1 of 1
Year: 2020 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-05 Sente

Carlsbad, California, United States

Sente is a privately held specialty aesthetics company leveraging its expertise and foundation in biotechnology to deliver novel, science-based skincare products. The company is a recognized leader in the development of innovative and targeted medical skincare products based on glycosaminoglycans. Their products are available through an exclusive network of physicians and medically supervised spas. Sente was founded in 2007 and based in Carlsbad, California.

Buy -
Mergr

Solution for

Product

Company

Legal